Biogen Inc (NASDAQ: BIIB)

DRUGS - Biotechnology
Sector: Health Care

Stock price data as of 09/20/2019

Closing price: 238.79

Support price level:	$225.16
Resistance price level:	$241.74
Relative strength index (14-day RSI)	74.4
Beta	1.26

With a -29.5 percent return in the past year, this stock is among the worst 10 percent of performers in the S&P-100.
BIIB is one of this week's most volatile stocks in the S&P-100 with an estimated annualized standard deviation of 36.6%.
Volatility is forecast to fall over the next month.
With RSI > 70, BIIB is overbought. Odds slightly favor a short-term price reversal.

Low	High	Price as % of Range
$216.71	$355.60	19.6%

200 day	50 day	20 day	10 day
$263.75	$232.47	$228.45	$235.23

(Annualized standard deviation)

Historical (5 year)	Last month	Current estimate	Next month forecast
36.7%	36.1%	36.6%	36.8%

There is an estimated 5% probability that the stock price of Biogen Inc will fall by more than: